| |
\
|
|
| Join us online |
 |
 |
| |
| |
|
| |
|
| |
|
|
|
 |
im·po·tence -
\im-pə-tən(t)s\
noun
-- the quality or state of being impotent;
--
the inability to achieve or maintain an erection long enough to engage in sexual intercourse
Learn more about impotency here
Click this link for a full report on erectile dysfunction |
 |
NOTE: This section contains resesrch and testimony of medical professionals,
practitioners and other organizations. The views, opinions and data expressed here are for educational purposes only, and do not warrant the opinions of TalkOnDiabetes Please read the disclaimer first before continuing. |
 |
Diagnosed diabetes in people younger than 20 years of age, United States, 2010
About 215,000 people younger than 20 years have diabetes (type 1 or type 2). This represents 0.26% of all people in this age group. Estimates of undiagnosed diabetes are unavailable for this age group. |
|
CDC: Diagnosed and undiagnosed diabetes in the United States, all ages, 2010
Prevalence and Trends in Obesity Among US Adults, 1999-2008
view powerpoint slide
U.S. Obesity Trends by State 1985–2008
view powerpoint slide
CDC: National Diabetes Fact Sheet, 2007
Public Health Agency of Canada: National Diabetes Fact Sheets Canada 2008
New England Journal of Medicine: Prevalence of Diabetes among Men and Women in China - subscription needed |
|
Pathogenesis:
How Diabetes Insipdius is Neurophysically Acquired
Pituitary hypothalamic surgery
Head trauma
Neoplasms
Hypothalamic (craniopharyngioma, germinoma, meningioma)
Anterior pituitary
(suprasellar extension)
Metastatic (lung, breast, leukemia, lymphoma)
Granulomas (neurosarcoid, histiocytosis, tuberculosis, Wegener's dz)
Infections (chronic
meningitis, encephalitis)
Congenital malformations (e.g. holoprosencephaly)
Ischemia (shock, Sheehan's syndrome, aortocoronary bypass, TTP)
Aneurysms (cavernous part of internal carotid)
Hematoma
Inflammation (lymphocytic infundibulon-
eurohypophysitis or hypophysitis)
Chemical toxins
(tetrodotoxin, snake venom, ethanol-induced [transient])
Autoimmune
Miscellaneous
Post-supraventricular tachycardia
Anorexia nervosa
Acute fatty liver of pregnancy
Cysts
Guillain-Barré syndrome
Genetic
Autosomal dominant (AVP-neurophysin II gene mutations)
Wolfram syndrome
Idiopathic (30% of cases of central DI)
MORE MEDICAL DETAILS ON DIABETES INSIPIDUS... |
| |
| |
| |
| |
|
NEXT PAGE >> |
L |
 |
| Gestational Diabetes PDF |
Relationship Between Ethnicity and Glycemic Control, Lipid Profiles, and Blood Pressure During the First 9 Years of Type 2 Diabetes PDF |
| Pregnancy in Preexisting Diabetes PDF |
High Prevalence of Type 2 Diabetes in All Ethnic Groups, Including Europeans, in a British Inner City PDF |
| Diabetes Trends in the U.S : 1990-1998 PDF |
Maternal Transmission of Type 2 Diabetes Varies by Ethnic Group PDF |
| Hyperglycemic Crises in Patients With Diabetes Mellitus PDF |
Plasma Lipoprotein Subpopulation Distribution in Caucasian and African-American Women With Gestational Diabetes PDF |
| Physical and Metabolic Characteristics of Persons with Diabetes PDF |
Racial and Ethnic Differences in Health Care Access and Health Outcomes for Adults With Type 2 Diabetes PDF |
| Diagnosis, Classification, and Lifestyle
Treatment of Diabetes PDF |
Summary Health Statistics for U.S. Adults: 2007 PDF |
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 PDF |
Diabetes Disparities Among Racial and Ethnic Minorities PDF |
|
 |
More about Type-1 Diabetes and Cow's Milk:
The evidence incriminating cows milk consumption in the cause of type-1 diabetes is sufficient to cause the American Academy of Pediatrics to issue these warnings, "Early exposure of infants to cow's milk protein may be an important factor in the initiation of the beta cell (insulin-producing cells of the pancreas) destructive process in some individuals."20 "The avoidance of cow's milk protein for the first several months of life may reduce the later development of IDDM or delay its onset in susceptible people."20
Exposure to cows milk protein early in life, when the intestinal tract is immature, sometimes results in the milk protein entering the blood stream where antibodies to this foreign substance, cows milk, are made by the immune system. Unfortunately, these same antibodies also attack the insulin-producing cells of the pancreas. By glassful of milk after spoonful of ice cream, over a period of about 5 to 7 years, the child destroys his or her own pancreas and is left with a lifelong, life-threatening, handicap: diabetes. The pancreas is forever destroyed and the child will have to take insulin shots daily. Complications, such as blindness, kidney failure, and heart disease will be a real threat during his or her shortened lifespan.
Thanks to Travelworks.com
▲ Back to top |
Bacteria and Diabetes: Important Notes
All diabetic persons also carry a virus, HA virus in the pancreas. This virus is grown in the skin as a wart but is spread quite widely in the body such as in the spleen or liver besides pancreas. It is not necessary to kill the virus since it disappears when the pancreatic fluke is gone. The HA virus undoubtedly belongs to the pancreatic fluke. The question can be asked: Does the fluke or its virus cause diabetes? There might even be a bacterium, so far missed in our observations, that is the real perpetrator.
All diabetics have a common fluke parasite, Eurytrema pancreaticum, the pancreatic fluke of cattle, in their own pancreas. It seems likely that we get it from cattle, repeatedly, by eating their meat or dairy products in a raw state. It is not hard to kill with a zapper but because of its infective stages in our food supply we can immediately be reinfected.
Eurytrema will not settle and multiply in our pancreas without the presence of wood alcohol (methanol). Methanol pollution pervades our food supply -- it is found in processed food including bottled water, artificial sweetener, soda pop, baby formula and powdered drinks of all kinds including health food varieties. I presume wood alcohol is used to wash equipment used in manufacturing. If your child has diabetes, use nothing out of a can, package or bottle except regular milk, and no processed foods.
By killing this parasite and removing wood alcohol from the diet, the need for insulin can be cut in half in three weeks (or sooner!).
Be vigilant with your blood sugar checks. The pancreas with its tiny islets that produce insulin recovers very quickly. Even if 90% of them were destroyed, requiring daily insulin shots, half of them can recover or regenerate so insulin is no longer necessary. The insulin shot itself may be polluted with wood alcohol (this is an especially cruel irony -- the treatment itself is worsening the condition). Test it yourself, using the wood alcohol in automotive fluids (windshield washer) or from a a pint store, as a test substance. Try different brands of insulin until you find one that is free of methanol.
Artificial sweeteners are polluted with wood alcohol! Instead of helping you cope with your diabetes, they are actually promoting it! Do not use them.
Source: Dr. Hulda Clark
▲ Back to top |
|
 |
|
RESEARCH:
Diabetes in Asia
Epidemiology, Risk Factors, and Pathophysiology
Context With increasing globalization and East-West exchanges, the increasing epidemic of type 2 diabetes in Asia has far-reaching public health and socioeconomic implications.
Objective To review recent data in epidemiologic trends, risk factors, and complications of type 2 diabetes in Asia.
More Details |
Estimation of diabetes worldwide in 2025 JPG - click below for larger image
 |
|
 |
|
|
Einstein College of Medicine Receives $600,000 Grant to Study Resveratrol's Impact on Pre-Diabetes
The Albert Einstein College of Medicine at Yeshiva University in New York City has received a $600,000 grant from the AmericanDiabetes Association to study the effects of resveratrol on lowering impaired glucose tolerance in older adults.
Impaired glucose tolerance-the inability to use insulin properly-is one of the main conditions of pre-diabetes. According to the ADA, almost 40 percent of adults over age 60 have IGT or diabetes. Pre-diabetes itself, says the association, increases the risk of heart attack or stroke by 50 percent.
Resveratrol, a chemical compound commonly found in red wine and grapes, has been found in previous research studies involving laboratory animals to have a beneficial effect on glucose metabolism. But there have been no formal studies with humans.
The six-week study will focus on 30 subjects between the ages of 50 and 80 who have IGT. Some participants in the double-blind study will receive resveratrol supplements while others will receive a placebo.
The object of the research will be to see resveratrol's effects on blood glucose levels after meals. Further study will look into the chemical compound's effects on muscle cell and blood vessel functions.
Word about resveratrol's beneficial effects has circulated for several years, especially in light of the compound's natural occurrence in red wine. But it turns out that to receive a dose of resveratrol sufficient to affect blood glucose levels, a wine drinker would have to imbibe more than 100 bottles of wine per day-an impossibility from the standpoint of health, finances, and efficiency.
Several manufacturers sell resveratrol supplements, usually in 100 mg, 250 mg, or 500 mg doses. However, nobody is yet certain what should be a standard daily dose and what should be considered an overdose.
(Anecdotal information on the Internet seems to put the upper limit at 5,000 mg daily. Supposed side effects from too much resveratrol can include joint aches and stomach pains. Because the compound is a blood thinner, users are cautioned to tell their doctors if they are also taking prescribed blood thinners.) |
|
|
Research on Stevia - Natural Sweetener
Stevia has garnered attention with the rise in demand for low-carbohydrate, low-sugar food alternatives. Stevia also has shown promise in medical research for treating such conditions as obesity and high blood pressure. Stevia has a negligible effect on blood glucose, even enhancing glucose tolerance; therefore, it is attractive as a natural sweetener to diabetics and others on carbohydrate-controlled diets.
Studies showed no adverse effects of steviol glycosides when taken at doses of about 4 mg per day. In December 2008, the US Food and Drug Administration (US FDA) stated it had no objection to the conclusion of an expert panel that rebaudioside A is generally recognized as safe (GRAS) for use as a general purpose sweetener. Prior to this, stevia-based ingredients were only permitted for use as a dietary supplement in the U.S. Scientific data on steviol glycosides, including rebaudioside A (used in rebiana) and concluded that they are safe for their intended use - to sweeten foods and beverages and established a permanent Acceptable Daily Intake (ADI) level. Click here For more details.
Canadian Diabetes Association National Nutrition Committee Technical Review: Non-nutritive Intense Sweeteners in Diabetes Management
A Compilation of the Current and Past Evidence Regarding Stevia
JOINT FAO/WHO EXPERT COMMITTEE ON FOOD ADDITIVES, 17-26 June 2008
▲ Back to top |
|
| |
 |
| Diabetes is the fifth leading cause of death by disease in the U.S. Diabetes afflicts 120 million people worldwide, and the World Health Organization estimates that number to skyrocket to 300 million by 2025. |
|
|
| |
| Sign up for our newsletter, featuring news updates and more information! |
|
|
| |
All featured journals are in PDF format and are the property of their respective owners.
You can download Adobe
Reader here
 |
|
| CLINICAL NOTES |
Clinical Trials to Test
Chinese Herb's Efficacy To Treat Obesity Under Way
Researchers have begun clinical trials to find out how well an anti-obesity compound derived from a Chinese herb works in humans.
Bioheart announces primary focus on completing clinical evaluation of cell therapies for heart failure
Bioheart, Inc. (OTCBB:BHRT) announced today that Bioheart's primary focus is on completing clinical evaluation of its cell therapies for treating heart failure and related cardiac diseases.
Pharmasset, Bristol-Myers Squibb collaborate for proof of concept study on chronic HCV
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus (HCV).
PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
The purpose of this study is to establish the safety and efficacy of multiple administrations of PROCHYMAL® in subjects recently diagnosed with type 1 diabetes mellitus
Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes (anti IL-1)
Canakinumab is a fully human anti-interleukin-1β (anti-IL-1β) monoclonal antibody (IgG-1 class). Canakinumab is designed to bind to human IL-1β and to functionally neutralize the bioactivity of this pro-inflammatory cytokine.
Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes (START)
Thymoglobulin is an antibody preparation that is commonly used to treat and prevent organ transplant rejection. The START trial aims to determine whether Thymoglobulin treatment can halt the progression of newly diagnosed type 1 diabetes when given within 12 weeks of disease diagnosis.
Effect of Diabetes Mellitus on Cholesterol Metabolism
HMG CoA reductase inhibitors (statins) are commonly used to treat high cholesterol (HC) in both type 1 and type 2 diabetes mellitus (DM). Several studies have shown benefits of statin among patients of type 2 DM, however, no such data is available for patients with type 1 DM.
US Approves New Trial of Embryonic Stem Cells on Blindness
US biotech company Advanced Cell Technology on Monday said that government has cleared to start its second trail using human embryonic stem cells to treat blindness, in older people. |
| |
| |
| |
| |
| |
| |
|
| |
|
|
|
|